From Cancer to COVID‐19: A Perspective on Targeting Heparan Sulfate‐Protein Interactions onlinelibrary.wiley.com/doi/10.1002/tc… An account of our work on heparan sulfate mimetics over the years. Thanks to @NehaGan53599560, @MohitCh25978605, @_nwsee and Gareth Doherty.

Introducing our #Board - Meet RakeshVeedu, our Founder and Managing Director A Perron Institute #McCusker fellow and the head of the #NucleicAcid #Therapeutics Research based at the Centre for Molecular Medicine and Innovative Therapeutics Murdoch University lnkd.in/gxXayJRD

Introducing our #Board - Meet #MarvinCaruthers, our Founding Director For many known as the father of #Oligonucleotide #synthesis and co-founder of Amgen 🧪🔬🧬, Applied Biosystems, Array BioPharma and miRagen Therapeutics syngenis.com/marvin-caruthe…

Introducing our #Board - Meet Martin Blake, our Founding Director Serial #entrepreneur and currently chairman of @PerthRadClinic and Resonance Health Ltd syngenis.com/martin-blake/

Introducing our #CompanyBoard - Meet Steve Arnott, our Chairman A wealth of #BusinessExpertise and currently the CEO of Perron Institute syngenis.com/steve-arnott/

Exciting new results on #antisenseoligonucleotides and #siRNA research by the Rakesh Singh N. Veedu and Hiroshi Abe teams. Congratulations! …mistry-europe.onlinelibrary.wiley.com/doi/10.1002/cb…

Join us at #ISNAC2021 organised by #JSNAC next week to hear the latest on #oligonucleotide and #nucleicacid research! isnac2021.jp

Proud to receive an MTPConnect #Manufacturing voucher to establish #ISO and #GMP certification for our products! Thanks to the WA Life Sciences Innovation Hub! syngenis.com/manufacturing-…

Introducing our #CompanyBoard - Meet George Bautovich, our founding director. Currently #Nuclear #Medicine #physician in the Department of Nuclear Medicine at Royal North Shore Hospital syngenis.com/george-bautovi…

Syngenis, Epichem, Gene S and Xytovet received a small business grant from the Town of Victoria Park to showcase #Biotechnology #TechPark. So mark your calendars for the 18th March 2022 from 10AM to 2PM to experience the best what Tech Park has to offer! syngenis.com/syngenis-showc…

Thank you If Innovation Could Talk for giving us an opportunity to discuss about SynGenis. It has been a wonderful experience sharing our passion, expertise and capabilities in oligonucleotide manufacturing. linkedin.com/posts/syngenis…

#HarmonyDay celebrations at #Syngenis. #DiversityandInclusion Read more: linkedin.com/feed/update/ur…

Meet Emma Carr, Our Operations Officer at Syngenis. Emma loves to challenge her strength through rock climbing and enjoy exploring marine life through her scuba diving adventures. To find out more about Emma's background, visit syngenis.com/emma-carr/

Meet Silvana Carnachan, our Head of Quality and Regulatory Affairs at Syngenis. To find out how Silvana’s role assists in producing and providing high quality oligonucleotides, visit syngenis.com/silvana-carnac…